Zeldes Haeggquist & Eck, LLP Announces Investigation of Unilife Corporation
September 26, 2013
SAN DIEGO--(EON: Enhanced Online News)--Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into whether officers and directors of Unilife Corporation (“Unilife” or the “Company”) have breached their fiduciary duties to shareholders.
Unilife (NASDAQ: UNIS) is a developer, manufacturer, and supplier of injectable drug delivery systems such as prefilled syringes. On September 4, 2013, an article was published in Forbes magazine questioning the accuracy of Unilife’s financial statements. On this news, shares of Unilife fell more than 14% from the previous day’s close, from $3.55 to $3.03.
Shortly thereafter on September 9, 2013, former Unilife Vice President Talbot Smith filed a whistleblower complaint alleging that the Company violated federal securities laws by making several misrepresentations to shareholders and the market. Smith further alleged that the Unilife board of directors was aware of the alleged wrongdoing. Our investigation focuses on whether Unilife’s board of directors breached its fiduciary duties to shareholders in connection with the alleged securities law violations.
If you are a Unilife shareholder, you may have legal claims against Unilife’s board of directors. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Amber L. Eck at 619-342-8000, or by email at [email protected]. There is no cost to you.
Zeldes Haeggquist & Eck, LLP is a full-service law firm which brings major class actions nationwide on behalf of defrauded investors and consumers and handles a variety of complex business litigation matters. Please visit www.zhlaw.com or our blog for more information about the firm.
